PUSHING THE LIMITS OF MEDICAL TECHNOLOGY ON THE ROOF OF THE WORLD
In the spring of 1999, just before the monsoon descended upon the Himalayas, physician-climbers and scientists brought a novel telemedicine program from the Yale School of Medicine to the remote and harsh environment of the Base Camp of Mount Everest. They implemented and tested new telemedicine technologies in a high-altitude environment well-known to push humans to the limits of their physiologic adaptability.
Telemedicine, which "utilizes electronic information and communications technologies to provide and support health care when distance separates the participants" [1] was rigorously evaluated in the Himalayas. The high-altitude environment of Everest Base Camp, at 17,500 feet above sea level, set an ideal stage for evaluating telemedicine's provision of advanced medical care in an isolated and distant location. The atmospheric conditions on the mountain stresses the physiology of climbers considerably in their quest for the summit. Taking into consideration the oxygen cascade from atmosphere to mitochondria, it is truly remarkable that elite climbers can respirate sufficiently to travel at these extremely high-altitudes at all. By quantitatively considering the requisite factors for effective respiration, such as the convective ventilation from atmosphere to alveolus, diffusion across the gasblood barrier, uptake by hemoglobin in pulmonary capillaries, convective flow of oxygenated blood to peripheral capillaries, gas exchange between hemoglobin and tissues, and finally the diffusion of oxygen to mitochondria for utilization in the electron transport system, it has been calculated that at the summit of Mount Everest, a climber breathes oxygen that is very near the absolute lowest partial pressure tolerable for a human [2] . Extreme 
MONITORING CLIMBERS' PHYSIOLOGY AS THEY STRUGGLE TO ASCEND THE ROOF OF THE WORLD
A second focus of the Everest Extreme Expedition involved the remote monitoring of climbers performing in extreme climates and altitudes where significant danger is always an issue. In 1996, eight climbers were caught in a fierce storm high on the mountain and were killed while trying to descend. This wellpublicized tragedy, which occurred on the south side of Mount Everest, was fresh in the minds of those developing the plans for the 1998 E3 project. This reminder served as a backdrop to the proposal that physiological monitoring devices might be used to provide a new margin of safety to personnel in remote and harsh environments. Monitoring heart rate, surface and core temperatures, exact location, and whether an individual is moving or stationary would have significant value in attempting to save the lives of hapless climbers. The PED was developed and tested by the U.S. Army's Natick laboratories and taken to Mount Everest by the E3 team for evaluation. The PED measures cardiac pulse rate, skin temperature, and extremity motion by way of skin electrodes, body core temperature from a 1 cm capsule swallowed by the climber, and position through a Global Positioning System unit. This information was relayed by radiofrequency transmission through repeaters on the mountain to Base Camp, and then onto New Haven. The PEDs were tested both along the trekking route as the team ascended the lower flanks of the mountain, and in Base Camp.
The devices were ultimately worn by those western climbers and Sherpas who ascended above Base Camp to Camp One. Their physiologic condition and their location was carefully monitored as they wound their way for nine and a half hours beneath the teetering seracs and everthreatening deep crevasses of the Khumbu Icefall, one of the most dangerous sections of the route to the summit on the south side of Mount Everest. Real-time access to the PED data provided continuous reassurance as to the climbers' conditions and progress, and could be used to assess and locate the climbers in the event that a rescue became necessary. This evolving application of telemedicine will be invaluable in helping to insure the safety of personnel in extreme environments, whether it be on the flanks of far-away mountain ranges or beyond the earth's atmosphere altogether.
HIGH-ALTITUDE PHYSIOLOGICAL INVESTIGATIONS
Physiologic research was carried out by investigators on the E3 team; data were collected from individuals as they were strained by and adapted to the high-altitude environment. While the respiratory response to hypoxia has been thoroughly investigated and is well-understood, the cardiovascular adaptation to high altitude is less extensively studied, primarily due to the difficulties inherent in measurement. The invasive techniques used to measure cardiac output, for example, are prohibitively difficult to carry out in remote high-altitude conditions. The ability to measure cardiovascular function in remote mountain locales would be a major step toward understanding the cardiovascular adaptation to high altitude. In 1999, E3 researchers used a portable Doppler ultrasound instrument to quantify blood flow in the carotid, brachial, and posterior tibial arteries of subjects at high altitude. Blood flows were measured in team members as they ascended to high altitude and while they underwent the physiologic adaptation to the low partial pressures of oxygen in such a lofty atmosphere. These measurements of blood flow were recorded, using ruggedized laptop computers. These data were followed for both Western climbers as they acclimatized to the high-altitude environment 
